HPA Axis Study in Adults
NCT01408511
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Eczema
Interventions
DRUG:
Mapracorat
Sponsor
Bayer